Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.

ClinicalTrials.gov ID: NCT00611026

Public ClinicalTrials.gov record NCT00611026. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

12-Week, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multicenter Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Comparison To Tolterodine ER In Patients With Overactive Bladder.

Study identification

NCT ID
NCT00611026
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
2,417 participants

Conditions and interventions

Interventions

  • Tolterodine ER Drug
  • Placebo Drug
  • Fesoterodine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2008
Primary completion
Sep 30, 2009
Completion
Sep 30, 2009
Last update posted
Feb 1, 2011

2008 – 2009

United States locations

U.S. sites
102
U.S. states
34
U.S. cities
88
Facility City State ZIP Site status
Pfizer Investigational Site Enterprise Alabama 36330
Pfizer Investigational Site Mobile Alabama 36608
Pfizer Investigational Site Montgomery Alabama 36117
Pfizer Investigational Site Chandler Arizona 85225
Pfizer Investigational Site Peoria Arizona 85381
Pfizer Investigational Site Tucson Arizona 85741
Pfizer Investigational Site Little Rock Arkansas 72205
Pfizer Investigational Site Anaheim California 92801
Pfizer Investigational Site Clovis California 93611
Pfizer Investigational Site Fresno California 93710
Pfizer Investigational Site Fresno California 93720
Pfizer Investigational Site San Diego California 92103
Pfizer Investigational Site Torrance California 90505
Pfizer Investigational Site Upland California 91786
Pfizer Investigational Site Vista California 92083
Pfizer Investigational Site Westlake Village California 91361
Pfizer Investigational Site Englewood Colorado 80112
Pfizer Investigational Site New London Connecticut 06320
Pfizer Investigational Site Bonita Spring Florida 34134
Pfizer Investigational Site Hollywood Florida 33021
Pfizer Investigational Site Jacksonville Florida 32205
Pfizer Investigational Site Jacksonville Florida 32216
Pfizer Investigational Site Lake Worth Florida 33461
Pfizer Investigational Site Leesburg Florida 34748
Pfizer Investigational Site Longwood Florida 32779
Pfizer Investigational Site Loxahatchee Groves Florida 33470
Pfizer Investigational Site Miami Florida 33143
Pfizer Investigational Site Miami Florida 33186
Pfizer Investigational Site Naples Florida 34102
Pfizer Investigational Site Pembroke Pines Florida 33024
Pfizer Investigational Site Stuart Florida 34996
Pfizer Investigational Site Tallahassee Florida 32308
Pfizer Investigational Site West Palm Beach Florida 33409
Pfizer Investigational Site Atlanta Georgia 30308
Pfizer Investigational Site Atlanta Georgia 30342
Pfizer Investigational Site Meridian Idaho 83642
Pfizer Investigational Site Chicago Illinois 60654
Pfizer Investigational Site Peoria Illinois 61614
Pfizer Investigational Site Avon Indiana 46123
Pfizer Investigational Site Evansville Indiana 47714
Pfizer Investigational Site Noblesville Indiana 46158
Pfizer Investigational Site Overland Park Kansas 66210
Pfizer Investigational Site Overland Park Kansas 66215
Pfizer Investigational Site Lexington Kentucky 40504
Pfizer Investigational Site Lexington Kentucky 40509
Pfizer Investigational Site Louisville Kentucky 40207
Pfizer Investigational Site Louisville Kentucky 40291
Pfizer Investigational Site Metairie Louisiana 70002
Pfizer Investigational Site Baltimore Maryland 21211
Pfizer Investigational Site Bel Air Maryland 21014
Pfizer Investigational Site North Dartmouth Massachusetts 02747
Pfizer Investigational Site Ann Arbor Michigan 48103
Pfizer Investigational Site Royal Oak Michigan 48073
Pfizer Investigational Site Troy Michigan 48098
Pfizer Investigational Site Edina Minnesota 55435
Pfizer Investigational Site Sartell Minnesota 56377
Pfizer Investigational Site Olive Branch Mississippi 38654
Pfizer Investigational Site Picayune Mississippi 39466
Pfizer Investigational Site Kansas City Missouri 64114
Pfizer Investigational Site St Louis Missouri 63117
Pfizer Investigational Site Lincoln Nebraska 68506
Pfizer Investigational Site Lincoln Nebraska 68510
Pfizer Investigational Site Omaha Nebraska 68134
Pfizer Investigational Site Las Vegas Nevada 89148
Pfizer Investigational Site Hamilton New Jersey 08690
Pfizer Investigational Site Williamsville New York 14221
Pfizer Investigational Site Cary North Carolina 27518
Pfizer Investigational Site Raleigh North Carolina 27609
Pfizer Investigational Site Raleigh North Carolina 27612
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Cincinnati Ohio 45212
Pfizer Investigational Site Cincinnati Ohio 45249
Pfizer Investigational Site Bensalem Pennsylvania 19020
Pfizer Investigational Site Philadelphia Pennsylvania 19114
Pfizer Investigational Site Pittsburgh Pennsylvania 15243
Pfizer Investigational Site Uniontown Pennsylvania 15401
Pfizer Investigational Site Cumberland Rhode Island 02864
Pfizer Investigational Site Pawtucket Rhode Island 02860
Pfizer Investigational Site Anderson South Carolina 29621
Pfizer Investigational Site Greer South Carolina 29651
Pfizer Investigational Site Summerville South Carolina 29485
Pfizer Investigational Site Johnson City Tennessee 37601
Pfizer Investigational Site Nashville Tennessee 37203
Pfizer Investigational Site New Tazewell Tennessee 37825
Pfizer Investigational Site Beaumont Texas 77701
Pfizer Investigational Site Beaumont Texas 77706
Pfizer Investigational Site Bryan Texas 77802
Pfizer Investigational Site Plano Texas 75024
Pfizer Investigational Site Plano Texas 75093
Pfizer Investigational Site San Antonio Texas 78229
Pfizer Investigational Site Sugar Land Texas 77479
Pfizer Investigational Site Midvale Utah 84047
Pfizer Investigational Site West Jordan Utah 84088
Pfizer Investigational Site Arlington Virginia 22205
Pfizer Investigational Site Charlottesville Virginia 22911
Pfizer Investigational Site Richmond Virginia 23294
Pfizer Investigational Site Virginia Beach Virginia 23455
Pfizer Investigational Site Virginia Beach Virginia 23464
Pfizer Investigational Site Weber City Virginia 24290
Pfizer Investigational Site Seattle Washington 98104
Pfizer Investigational Site Seattle Washington 98166
Pfizer Investigational Site Spokane Washington 99207

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 125 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00611026, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 1, 2011 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00611026 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →